Tempest Therapeutics, Inc.
TPST—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-6.33
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$295,000
Net income
$-26.26M
Net margin
-8902.4%
Gross margin
—
Dividends & financials
Tempest Therapeutics, Inc. (TPST) reported revenue of $295,000 and net income of $-26.26M, or $-6.33 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
